Molecular Partners AG
NASDAQ:MOLN · NASDAQ Global Select
+$0.03 today
Vol 0.00M · Avg 0.00M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+6.70%
Period High
$5.13
Period Low
$3.47
Latest
$3.82
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Nkarta, Inc.
NASDAQ:NKTX
$194.96M
Alector, Inc.
NASDAQ:ALEC
$182.64M
PepGen Inc.
NASDAQ:PEPG
$124.85M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$112.51M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.48M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.39M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$71.67M
Cassava Sciences, Inc.
SAVA
$63.77M
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
$50.77M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest MOLN filing?
The latest filing shown is 6-K dated Jun 1, 2026.
How many recent filings does MOLN have?
Intrinsic Alpha currently shows 20 recent filings for MOLN.
Explore More
Continue the stock analysis
Jump to another research area for this company.